Consistent with the reported inhibitory role of CD59 in complement-mediated lysis (CML), knocking out CD59 in CD4+ T cells renders both HIV-1-infected cells and progeny virions more prone to antibody-dependent CML (ADCML). The gene discussed is CD4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.